
Sarah Carol Fiallo MD (She/her)
Preventive Medicine, Women's Health, Obesity Medicine & Nutrition
Physician
Join to view full profile
20 Elm StWestport, CT 06880
Phone+1 888-663-6331
Fax+1 203-604-1053
Dr. Fiallo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sarah Fiallo, MD, is a healthcare provider specializing in Family Medicine based in Westport, CT. She also has subspecialties in Adolescent Medicine, Hospital Medicine/Hospitalist, and Hospital Pediatrics/Pediatric Hospitalist. Her educational journey includes residency and chief residency in Family Medicine at Arnot Ogden Medical Center, medical degree from St. George's University School of Medicine, and a Bachelor's degree in Chemistry at New York University. Dr. Fiallo currently holds a position as a Research Fellow at New York University School of Medicine. Her published work includes studies on the pancreatic cancer microbiome and its effects on immune suppression.
Education & Training
Arnot Ogden Medical CenterChief Residency, Family Medicine, 2020 - 2021
Arnot Ogden Medical CenterResidency, Family Medicine, 2018 - 2020
St. George's University School of MedicineClass of 2015
New York UniversityBS, Chemistry
Certifications & Licensure
IL State Medical License 2025 - 2029
ME State Medical License 2025 - 2028
VA State Medical License 2026 - 2028
MI State Medical License 2025 - 2028
AR State Medical License 2026 - 2028
MD State Medical License 2026 - 2028
DC State Medical License 2026 - 2028
American Board of Family Medicine Family Medicine- Join now to see all
Publications & Presentations
PubMed
- 1079 citationsThe Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune SuppressionSmruti Pushalkar, Mautin Hundeyin, Donnele Daley, Constantinos P. Zambirinis, Emma Kurz
Cancer Discovery. 2018-04-01 - 206 citationsNLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.Donnele Daley, Vishnu R. Mani, Navyatha Mohan, Neha Akkad, Gautam S.D. Balasubramania Pandian
The Journal of Experimental Medicine. 2017-06-05
Press Mentions
Gut Bacteria Determine Speed of Tumor Growth in Pancreatic CancerDecember 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









